Hepatitis B and Hepatitis C Co-infections in CLL: Implications and Management Strategies
Received Date: May 02, 2023 / Published Date: May 30, 2023
Abstract
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are classified as oncogenic human viruses. Chronic HBV and HCV infections are associated with higher risk of haematological malignancy development. Direct and indirect oncogenic mechanisms have been demonstrated for both HBV and HCV in several studies. HCV and overt/ occult HBV infections in patients with oncohaematological disease constitute an impediment and a threat during immunosuppressive chemotherapy treatment. We review the HBV and HCV oncogenic mechanisms and the impact and the safety of antiviral treatment in patients with haematological malignancies.
Citation: Michele C (2023) Hepatitis B and Hepatitis C Co-infections in CLL: Implications and Management Strategies. J Clin Infect Dis Pract, 8: 185. Doi: 10.4172/2476-213X.1000185
Copyright: © 2023 Michele C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 756
- [From(publication date): 0-2023 - Dec 19, 2024]
- Breakdown by view type
- HTML page views: 689
- PDF downloads: 67
